Loading quotes...
Forecast
There is no analyst data available for this company.
News Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Historical dividends Dividends
All dividend metrics All metricsFinancials
| (EUR) | 2023 | YoY |
|---|---|---|
| Revenue | 64.46M | 103.96% |
| Gross profit | 1.71M | 38.55% |
| Net profit | -7.57M | 59.07% |
| EBITDA | -5.06M | 70.20% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €641.12K |
Number of shares | 5.77M |
52-week high/low | €0.32 - €0.0953 |
| Dividends | No |
Beta | 1.43 |
P/E ratio | -0.17 |
PEG ratio | 0.00 |
P/B ratio | -17.47 |
P/S ratio | 0.01 |
Company profile
TAAT Global Alternatives Inc., a life sciences company, develops, manufactures, and distributes non-tobacco based smokable products in Canada and the United States. It offers nicotine-free and tobacco-free alternatives to traditional cigarettes under the TAAT brand. The company was formerly known as TAAT Lifestyle & Wellness Ltd. and changed its name to TAAT Global Alternatives Inc. in April 2021. TAAT Global Alternatives Inc. was incorporated in 2006 and is headquartered in Toronto, Canada.
| Name | TAAT Global Alternatives Aktie |
| CEO | Joel S. Dumaresq |
| Headquarters | Las Vegas,
nv Canada |
| Website | |
| IPO | 07/12/2017 |
Ticker symbols
| Exchange | Symbol |
|---|---|
Cnq | TAAT.CN |
Frankfurt | 2TP0.F |
Düsseldorf | 2TP0.DU |
München | 2TP0.MU |